2025 Expert Speaker Faculty

Amanda Placone, Eli Lilly

Amanda Placone

Senior director

Eli Lilly

Amanda Rohrig, BridgeBio Gene Therapy

Amanda Rohrig

Senior Director - Patient Advocacy

BridgeBio Gene Therapy

Amber freed

CEO & Founder

SLC6A1 Connect

Amy Raymond, PhD, PMP

Therapeutic Strategy Lead, Cellular & Genetic Medicines

Worldwide Clinical Trials

Anjulika Chawla, bluebird bio

Anjulika Chawla

Vice President - Medical Affairs

bluebird bio

Bennett Smith

Senior Vice President & General Manager

Orchard Therapeutics

Brian Kevany, Abeona Therapeutics

Brian Kevany

Senior Vice President, Chief Technical Officer & Chief Scientific Officer

Abeona Therapeutics

Costanza Gorini, Beacon

Costanza Gorini

Senior Researcher, Beacon Research Operations

Hanson Wade

Craig Malzahn, REGENXBIO

Craig Malzahn

Senior Vice President, Technical Operations

REGENXBIO

Daniel Chung, SparingVision

Daniel Chung

Chief Medical Officer

SparingVision

Delphine Agathon, Pfizer

Delphine Agathon

Senior Director & Category Clinician

Pfizer

Elizabeth Leshen, Novartis

Elizabeth Leshen

Head of Search & Evaluation, Gene Therapy and Rare Disease

Novartis

Francesca Cook

Vice President - Global Pricing & Market Access

REGENXBIO

Gail Ryan, Point32Health

Gail Ryan

Director - Pharmaceutical Transformation

Point32Health

Howard Wu, Full Circles Therapeutics

Howard Wu

Co-Founder & Chief Scientific Officer

Full Circles Therapeutics

Jean - Philippe, Vivet Therapeutics

Jean-Phillippe Combal

Co-Founder & Chief Executive Officer

Vivet Therapeutics

Jie Li, Vertex Pharmaceuticals

Jie Li

Director

Vertex Pharmaceuticals

Julie Batal

Vice President - Regulatory Science

bluebird bio

Kathleen Kirby, Merlin Therapeutics

Kathleen Kirby

Chief Operating Officer

Merlin Therapeutics

Kumar Dhanasekharan, Voyager Therapeutics

Kumar Dhanasekharan

SVP Technical Operations

Voyager Therapeutics

Lola Fashoyin-Aje, FDA

Lola Fashoyin-Aje

Director, Office of Clinical Evaluation- cell, tissue, gene therapies, CBER

FDA

Lucia Faccio

Partner

Sofinnova Partners

Mara Inniss, Obsidian Therapeutics

Mara Inniss

Director

Obsidian Therapeutics

Mark Trusheim, Tufts Medical Center

Mark Trusheim

Strategic Director, NEWDIGS

Tufts Medical Center

Marriane Lopez, Duke University

Marriane Hamilton Lopez

Senior Research Director

Duke University

Maryl Lambros, Avista Therapeutics

Maryl Lambros

Bioinformatics Scientist

Avista Therapeutics

Melissa Penn, Bayer

Melissa Penn

Director - Advocacy Relations Patient Engagement Research & Development

Bayer

Michael Rak, Carbon Biosciences

Michael Rak

Principal scientist

Carbon Biosciences

Mike Lehmicke

Senior Vice President for Science & Industry Affairs

Alliance for Regenerative Medicine

Morten Sogaard, Astellas Innovation Management

Morten Sogaard

President & Divison Head of Gene Therapy Research & Technical Operations

Astellas Innovation Management

Niccolo Bacchi, Borea Therapeutics

Niccolo Bacchi

Chief Executive Officer

Borea Therapeutics

Olivier Danos, REGENXBIO

Olivier Danos

Chief Scientific Officer

REGENXBIO

Peter Marks, FDA

Peter Marks

Director - Center for Biologics Evaluation & Research

FDA

Priya Chockalingam, Beam Therapeutics

Priya Chockalingam

Vice President & Head of Clinical Bioanalytics & Translational Sciences

Beam Therapeutics

Rajeev Boregowda, Sanofi

Rajeev Boregowda

Associate Director

Sanofi

Ravi Iyer, Script Biosciences

Ravi Iyer

Chief Scientific Officer

Script Biosciences

Richard Colvin

Chief Medical Officer

bluebird bio

Roelof Rongen

CEO

Adolore BioTherapeutics

Samir Koirala, Biogen

Samir Koirala

Head of Genetic, Neurodevelopmental & Epilepsy Disorders

Biogen

Sebastian Aguirre, Carbon Biosciences

Sebastian Aguirre Kozlouski

VP Platform Development

Carbon Biosciences

Sitra Tauscher W, Novartis

Sitra Tauscher-Wisniewski

VP

Novartis

Terry Cothran, Oklahoma Health Care Authority

Terry Cothran

Senior Pharmacy Director

Oklahoma Health Care Authority

Tynan Patrick, Pfizer

Tynan Patrick

Manager, Gene Therapy Purification Operations

Pfizer

Uditha DeAlwis, Sarepta

Uditha DeAlwis

Vice President, Analytical Sciences

Sarepta

Van Hoang, Spark Therapeutics

Van Hoang

Head of Analytical & Quality Controls

Spark Therapeutics

Vesselin Mitaksov, Pfizer

Vesselin Mitaksov

Associate Research Fellow

Pfizer

Vishwas Seshadri

President & Chief Executive Officer

Abeona Therapeutics

FULL EVENT GUIDE
REGISTER
PARTNER